Drug policy and women: addressing the negative consequences of harmful drug control

A number of reports have documented the negative consequences of current prohibitionist drug control policies on health, human rights and development, and these are the subject of growing international attention. The past thirty years has also seen a growing number of studies on women’s participation in all levels of the drug trade. However, limited research currently exists on the particular impact of drug control on women. This briefing paper focuses on this gap. This briefing aims to highlight the effects of drug policy on women as producers, suppliers and consumers of drugs in order to inform and guide policy makers on practices that should be avoided, as well as highlight those policies which effectively incorporate and address women’s needs. This briefing also features ‘snapshots’ from women and service providers working with women that are affected by drug policies. These snapshots explore the complex consequences that drug policies have on both individuals and services. Such snapshots also highlight examples of interventions that seek to address the negative consequences of drug control and provide positive support to women

Drug consumption rooms: evidence and practice.

For the past 10 to 20 years, drug consumption rooms (DCRs) have become an integrated part of the drug treatment and harm reduction strategy in a variety of countries in Western Europe, North America and Australia. However, they have not yet been established in the majority of countries worldwide. This briefing paper provides a short summary of the background, history and objectives of DCRs, and analyses available evidence regarding their impact. The second part of the briefing paper consists of an overview of the various DCRs in different countries, with a particular focus on the concepts used to develop these facilities with regard to the local political, cultural and social situation of each country

Taking stock of half a decade of drug policy - an evaluation of UNGASS implementation.

April 2021 marks the five-year anniversary of the 2016 United Nations General Assembly Special Session (UNGASS) on drugs. This report aims to take stock of progress made on the implementation of the operational recommendations included in the UNGASS Outcome Document. Using desk-based research, and drawing on data and analysis from UN reports, academia, civil society and the community, the report focuses on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation. While some progress has been undeniably made, the research gathered in this report shows that in the last five years the gap between policy commitments on paper and meaningful change on the ground has continued to widen